HIGHLIGHTS
- who: Chung-Un Lee and collaborators from the Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine have published the research work: Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions, in the Journal: Cancers 2022, 4174 of /2022/
- what: The authors evaluated the clinical utility of the prostate health index (PHI) for the diagnosis of PCa and clinically significant PCa (csPCa) in patients with PI-RADSv2 score-3 lesions. The continuous data in this paper were shown as median (interquartile range, IQR) and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.